Literature DB >> 12163091

Coronary Doppler measurements do not predict progression of cardiac allograft vasculopathy: analysis by serial intracoronary Doppler, dobutamine stress echocardiography, and intracoronary ultrasound.

Andreas König1, Christoph H Spes, Thomas M Schiele, Johannes Rieber, Hans U Stempfle, Bruno Meiser, Karl Theisen, Harald Mudra, Bruno Reichart, Volker Klauss.   

Abstract

Coronary flow velocity reserve (CFVR) (maximum/baseline flow velocity, 16 microg adenosine) was compared with dobutamine stress echocardiography (DSE) (5 to 40 microg/kg/min) to assess the progression of angiographically silent cardiac allograft vasculopathy (CAV). As a reference for the morphologic assessment of CAV, serial intracoronary ultrasound (ICUS) measurements were performed. An increase in CFVR could be observed in all transplant patients despite morphologic or functional progression of CAV or non-progressive CAV as assessed by ICUS or DSE. Thus, serial intracoronary Doppler flow analysis is not useful to predict morphologic or functional progression of CAV.

Entities:  

Mesh:

Year:  2002        PMID: 12163091     DOI: 10.1016/s1053-2498(01)00416-8

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  2 in total

1.  Changes in coronary anatomy and physiology after heart transplantation.

Authors:  Atsushi Hirohata; Mamoo Nakamura; Katsuhisa Waseda; Yasuhiro Honda; David P Lee; Randall H Vagelos; Sharon A Hunt; Hannah A Valantine; Paul G Yock; Peter J Fitzgerald; Alan C Yeung; William F Fearon
Journal:  Am J Cardiol       Date:  2007-04-19       Impact factor: 2.778

2.  Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.

Authors:  Jung-Min Ahn; Frederik M Zimmermann; Satish Arora; Ole-Geir Solberg; Oskar Angerås; Katrine Rolid; Muzammil Rafique; Lars Aaberge; Kristjan Karason; Kozo Okada; Helen Luikart; Kiran K Khush; Yasuhiro Honda; Nico H J Pijls; Sang Eun Lee; Jae-Joong Kim; Seung-Jung Park; Lars Gullestad; William F Fearon
Journal:  Eur Heart J       Date:  2021-12-21       Impact factor: 35.855

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.